Universal Health Services (NYSE:UHS) Price Target Lowered to $230.00 at TD Cowen

Universal Health Services (NYSE:UHS) had its target price lowered by investment analysts at TD Cowen from $245.00 to $230.00 in a report released on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the health services provider’s stock. TD Cowen’s target price points to a potential upside of 37.14% from the stock’s previous close.

Several other equities research analysts have also issued reports on the company. Robert W. Baird dropped their price target on Universal Health Services from $241.00 to $204.00 and set a “neutral” rating for the company in a research note on Wednesday. Guggenheim dropped their price target on Universal Health Services from $238.00 to $211.00 and set a “buy” rating for the company in a research note on Wednesday. Weiss Ratings lowered Universal Health Services from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, April 17th. Wall Street Zen raised Universal Health Services from a “hold” rating to a “buy” rating in a research note on Sunday, April 12th. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on Universal Health Services from $261.00 to $230.00 and set a “buy” rating for the company in a research note on Wednesday. Five analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $219.87.

Universal Health Services Price Performance

UHS stock traded up $5.17 during mid-day trading on Wednesday, hitting $167.71. 1,573,962 shares of the stock were exchanged, compared to its average volume of 755,644. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.05 and a quick ratio of 0.98. The business has a fifty day moving average price of $191.57 and a 200 day moving average price of $209.50. Universal Health Services has a 12 month low of $152.33 and a 12 month high of $246.32. The stock has a market capitalization of $10.24 billion, a price-to-earnings ratio of 6.99, a PEG ratio of 0.82 and a beta of 1.29.

Universal Health Services (NYSE:UHS) last issued its quarterly earnings results on Monday, April 27th. The health services provider reported $5.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.36 by $0.26. Universal Health Services had a return on equity of 19.78% and a net margin of 8.56%.The firm had revenue of $4.50 billion during the quarter, compared to analyst estimates of $4.39 billion. During the same quarter in the previous year, the company posted $4.84 earnings per share. The company’s revenue was up 9.6% compared to the same quarter last year. Universal Health Services has set its FY 2026 guidance at 22.640-24.520 EPS. On average, sell-side analysts anticipate that Universal Health Services will post 23.4 EPS for the current year.

Institutional Investors Weigh In On Universal Health Services

Hedge funds and other institutional investors have recently modified their holdings of the stock. Elyxium Wealth LLC bought a new stake in shares of Universal Health Services in the 4th quarter valued at about $25,000. SBI Securities Co. Ltd. lifted its stake in shares of Universal Health Services by 320.0% in the 3rd quarter. SBI Securities Co. Ltd. now owns 126 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 96 shares during the last quarter. Harbor Capital Advisors Inc. bought a new stake in shares of Universal Health Services in the 4th quarter valued at about $26,000. Root Financial Partners LLC bought a new stake in shares of Universal Health Services in the 3rd quarter valued at about $28,000. Finally, Founders Capital Management bought a new stake in shares of Universal Health Services in the 4th quarter valued at about $28,000. Institutional investors own 86.05% of the company’s stock.

Key Headlines Impacting Universal Health Services

Here are the key news stories impacting Universal Health Services this week:

• Positive Sentiment: Q1 results beat consensus — UHS reported $5.62 EPS and $4.50B revenue, ahead of estimates, with net income and year‑over‑year revenue growth driven in part by behavioral health admissions. UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 2026
• Positive Sentiment: FY‑2026 guidance provided: EPS guidance of 22.640–24.520 (roughly in line with the street) and revenue guidance around $18.4–18.8B, supporting a solid forward earnings outlook. Press Release / Guidance PDF
• Positive Sentiment: Behavioral-health strength highlighted as a key driver of the beat and revenue growth — a structural growth area that supports longer‑term margin and volume expectations. UHS’ Q1 Earnings Beat on Strong Behavioral Health Care Admissions
• Positive Sentiment: Zacks style/value coverage flags UHS as an attractively valued, long‑term value candidate — may support longer‑term investor interest despite near‑term volatility. Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term
• Neutral Sentiment: Earnings call transcript and detailed metrics are available for investors reviewing margins, payor mix and cost pressures to refine near‑term expectations. UHS Q1 2026 Earnings Call Transcript
• Negative Sentiment: RBC trimmed its price target from $216 to $190 and set a “sector perform” rating — a lower anchor that can weigh on sentiment and limit near‑term upside. RBC Cuts Price Target on Universal Health Services to $190
• Negative Sentiment: Robert W. Baird lowered its target to $204 and moved to neutral — another broker trimming upside expectations. Baird Lowers Price Target (news feed)
• Negative Sentiment: Deutsche Bank cut its target from $261 to $230 but kept a “buy” rating — shows confidence in the business but reduces the margin of safety implied by earlier targets. Deutsche Bank Adjusts UHS Price Target to $230

About Universal Health Services

Universal Health Services, Inc (NYSE: UHS) is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.

In the acute care segment, UHS’s facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.